Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients

This publication has 10 references indexed in Scilit:

• The safety and efficacy of B‐domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A
  Haemophilia, 2003
• Inhibitor Development in a Multitransfused Patient with Severe Haemophilia A
  Thrombosis and Haemostasis, 1999
• Appearance of an inhibitor to factor VIII in a hemophilia A patient with HIV infection treated with combination anti-retroviral therapy
  American Journal of Hematology, 1998
• Factor VIII Inhibitors in Previously Treated Haemophilia A Patients with a Double Virus-inactivated Plasma Derived Factor VIII Concentrate
  Thrombosis and Haemostasis, 1997
• Acquired factor VIII inhibitor associated with chronic interferon‐alpha therapy in a patient with haemophilia A
  British Journal of Haematology, 1994
• A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group
  Blood, 1993
• A Higher than Expected Incidence of Factor VIII Inhibitors in Multitransfused Haemophilia A Patients Treated with an Intermediate Purity Pasteurized Factor VIII Concentrate
  Thrombosis and Haemostasis, 1993
• The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors
  Blood, 1988